fluorodeoxyglucose f18 has been researched along with Hypoxia in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.19) | 18.7374 |
1990's | 3 (3.19) | 18.2507 |
2000's | 23 (24.47) | 29.6817 |
2010's | 47 (50.00) | 24.3611 |
2020's | 18 (19.15) | 2.80 |
Authors | Studies |
---|---|
Bechtel, S; Bryan, JN; Collins, A; Flesner, B; Henry, C; Lunceford, J; Maitz, CA; Saha, S; Tate, D; Tung, D; Varterasian, M; Zhang, L | 1 |
Bernardini, S; Camedda, R; Chiaravalloti, A; Fernandes, M; Izzi, F; Liguori, C; Manfredi, N; Mercuri, NB; Nuccetelli, M; Placidi, F; Schillaci, O | 1 |
Brnoliaková, Z; Daněk, J; Faridová, A; Folbergrová, J; Kala, D; Kapoor, S; Mikulecká, A; Otáhal, J; Svoboda, J | 1 |
Doi, H; Hanaoka, K; Hosono, M; Inada, M; Ishii, K; Kaida, H; Komanishi, M; Nakamatsu, K; Nishimura, Y; Uehara, T | 1 |
Katsuki, NE; Tago, M; Tokushima, M; Yamashita, SI | 1 |
Agarwal, JP; Arya, S; Budrukkar, A; Chatterjee, A; Ghosh-Laskar, S; Gupta, T; Murthy, V; Purandare, N; Rangarajan, V | 1 |
Bunea, H; Carles, M; Grosu, AL; Majerus, L; Meyer, PT; Mix, M; Nicolay, NH; Sörensen, A; Stoykow, C; Vaupel, P; Wiedenmann, NE | 1 |
Fan, B; Hu, M; Ma, L; Mu, D; Yang, G; Yu, J; Zhao, S; Zheng, J; Zhu, Y | 1 |
Aikawa, T; Anzai, T; Furuya, S; Hirata, K; Koyanagawa, K; Kudo, K; Kuge, Y; Magota, K; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Shiga, T; Tamaki, N; Tsujino, I | 1 |
Chen, J; Deivasigamani, A; Gao, H; Hui, KM; Kong, SN; Shi, M; Xia, H; Xie, T | 1 |
Bao, YN; Cui, YT; Huang, CX; Lin, Y; Tian, Y; Wang, XC; Yu, ZL; Zhang, JH | 1 |
Chung, JI; Jeon, J; Jo, H; Kim, SY; Ko, HY; Lee, J; Lee, M; Yun, M | 1 |
Schwartz, RG; Vidula, H | 1 |
Bai, Z; Ge, RL; Li, Y; Qi, G; Song, K; Wang, S; Yan, R; Yang, Y; Zhang, Y | 1 |
Christophi, C; Fang, C; Gan, H; Lee, ST; Liu, Z; Muralidharan, V; Pathmaraj, K; Sachinidis, J; Scott, AM; Tebbutt, N; Wong, P | 1 |
Andreev, DN; Bellaye, PS; Bonniaud, P; Bouchard, A; Cochet, A; Collin, B; Frenay, J; Goirand, F; Guillemin, M; Helbling, A; Kucheryavy, YA; Mayev, IV; Moreau, M; Mothes, C; Oudot, A; Tanguy, J | 1 |
Dong, XB; Ge, Y; Huo, Z; Li, TS; Wang, Q; Zhang, T | 1 |
Armitage, KB; Kalra, A; Lacey, MJ | 1 |
Aigbirhio, F; Emond, E; Endozo, R; Erlandsson, K; Fraioli, F; Ganeshan, B; Groves, AM; Hoath, J; Holman, B; Hutton, BF; Khan, S; Lukey, PT; Maher, TM; Porter, JC; Rashidnasab, A; Rodriguez-Justo, M; Screaton, NJ; Shortman, RI; Thielemans, K; Win, T | 1 |
Civelek, AC; He, ZX; Li, XF; Li, YM; Yao, Y | 1 |
Aigbirhio, FI; Davenport, AP; Figg, NL; Fryer, TD; Joshi, FR; Kirkpatrick, PJ; Manavaki, R; Rudd, JH; Sluimer, JC; Warburton, EA | 1 |
Huang, T; Jin, Z; Li, XF; Shen, B; Sun, Y | 1 |
Asada, Y; Iwakiri, T; Kawai, K; Kitamura, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y | 1 |
Dasu, A; Even, A; Lambin, P; Lindblom, E; Toma-Dasu, I; Uhrdin, J; van Elmpt, W; Wersäll, P | 1 |
Andrews, JPM; Dweck, MR; Fayad, ZA | 1 |
Axelrod, D; Kim, E; Melsaether, AN; Pujara, AC | 1 |
Izuishi, K; Kameyama, R; Masaki, T; Mori, H; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
Daemen, MJ; Marsch, E; Sluimer, JC | 1 |
Busk, M; Horsman, MR; Iversen, AB; Jakobsen, S; Ji, X; Lee, DY; Mortensen, LS; Nordsmark, M; Overgaard, J; Raleigh, JR | 1 |
Das, SK; Dewhirst, MW; Fels, DR; Hansen, KS; Vlahovic, G; Wong, TZ; Zhang, T | 1 |
Af Rosenschold, PM; Clausen, MM; Engelholm, SA; Hansen, AE; Kjaer, A; Kristensen, AT; McEvoy, FJ | 1 |
Abbate, C; Arosio, B; Chiara, LR; Deriz, M; Fenoglio, C; Ferri, E; Galimberti, D; Gussago, C; Mari, D; Nicolini, P; Rossi, PD; Scarpini, E; Serpente, M | 1 |
Ahmed, M; Codipilly, C; Dewey, S; Frattini, S; Huerta, PT; Marambaud, P; Miller, EJ; Nasim, M; Patel, H; Zaghloul, N | 1 |
De Ruysscher, D; Eriksson, J; Even, AJ; Hoebers, FJ; Houben, RM; Lambin, P; Mottaghy, FM; Ollers, MC; Reymen, B; Troost, EG; van Elmpt, W; Windhorst, AD; Zegers, CM | 1 |
Eskola, O; Grénman, R; Grönroos, TJ; Kronqvist, P; Laine, J; Lehtiö, K; Minn, H; Söderström, KO; Solin, O; Viljanen, T | 1 |
Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM | 1 |
Duan, X; Li, J; Li, XF; Ma, Y; Postel, GC; Wang, F; Wang, X; Yin, X; Zhang, G; Zheng, H | 1 |
Alba Castro, JL; Aramburu Núñez, D; Coolens, C; Del Olmo Claudio, JL; Driscoll, B; Landesa-Vázquez, I; López Medina, A; Mera Iglesias, M; Muñoz, V; Salvador Gómez, F | 1 |
Bezak, E; Jennings, M; Marcu, LG | 1 |
Bol, A; Bol, V; Bouzin, C; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Neveu, MA | 1 |
Hoebers, FJ; Lambin, P; Mottaghy, FM; Öllers, MC; Troost, EG; van Elmpt, W; Zegers, CM | 1 |
Clemmensen, AE; El Ali, HH; Hansen, AE; Kjær, A; Kristensen, AT; Oxboel, J; Zornhagen, KW | 1 |
Chirla, R; Marcu, LG | 1 |
Cammaroto, G; Caobelli, F; Di Mauro, F; Quartuccio, N | 1 |
Chowdhury, MM; Evans, NR; Rudd, JH; Sriranjan, RS; Tarkin, JM | 1 |
Faust, A; Hermann, S; Honold, L; Schäfers, M; Vrachimis, A | 1 |
Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
Busk, M; Bussink, J; Horsman, MR; Jakobsen, S; Overgaard, J; van der Kogel, A | 1 |
Altmann, A; Eisenhut, M; Haberkorn, U; Mier, W | 1 |
Aigbirhio, FI; Barnard, PJ; Bayly, SR; Betts, HM; Bonnitcha, PD; Christlieb, M; Dilworth, JR; Holland, JP; Honess, DJ; Hueting, R; King, RC | 1 |
Asai, T; Baba, H; Fan, X; Fujibayashi, Y; Morioka, K; Okazawa, H; Tanaka, K; Uchida, K; Zhuang, J | 1 |
Chan, YS; Chen, CH; Hou, CW; Huang, CY; Kuo, CH; Lee, SD; Lee, WC; Liu, YF; Tsai, YL | 1 |
Fujibayashi, Y; Fujieda, S; Furukawa, T; Kobayashi, M; Kudo, T; Mori, T; Oh, M; Tanaka, T | 1 |
Beato Tortajada, I; Bouché Babiloni, A; Conde Moreno, A; Ferrer Albiach, C; Francés Muñoz, A; Morillo Macías, V; Rodríguez Cordón, M; Sánchez Iglesias, A | 1 |
Bol, A; Christian, N; De Bast, M; Deheneffe, S; Grégoire, V; Labar, D; Lee, JA | 1 |
Humm, JL; Li, XF; Ling, CC; Ma, Y; O'Donoghue, JA; Sun, X | 1 |
Hwang, SH; Kim, IJ; Kim, SJ; Lee, CH; Lee, EY; Lee, MK; Lee, SY | 1 |
Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, CH | 1 |
Ahn, SD; Choi, EK; Choi, W; Im, KC; Jung, SH; Kim, JH; Kim, S; Lee, SW; Oh, SJ; Park, SH; Ryu, JS | 1 |
Chen, X; Gao, H; Mohamedali, KA; Niu, G; Quan, Q; Rosenblum, MG; Sun, X; Yan, Y; Yang, M; Zhang, W | 1 |
Fujibayashi, Y; Hata, H; Kitagawa, Y; Kotsuji, M; Nakamura, M; Okazawa, H; Sano, K; Yamazaki, Y; Yonekura, Y | 1 |
Christen, T; Di Carli, MF; Folco, EJ; Libby, P; Rocha, VZ; Sheikine, Y; Shvartz, E; Sukhova, GK | 1 |
Nguyen, PK; Wu, JC | 1 |
Cho, KJ; Choi, SH; Han, MW; Kim, JS; Kim, SY; Lee, HJ; Nam, SY; Roh, JL | 1 |
Izuishi, K; Masaki, T; Mori, H; Morishita, A; Nishiyama, Y; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
Celdran, M; Decatur, C; Feuer, W; Hernandez, E; Houston, SK; Lampidis, T; Lopez-Cavalcante, M; Murray, TG; Piña, Y; Shah, N | 1 |
Kitamura, N; Kwang-Lee, K; Sasabe, E; Uchida, M; Yamada, T; Yamamoto, T; Yoshimura, T | 1 |
Barranger, E; Barré, E; Baruch-Hennequin, V; Delord, M; Delpech, Y; Groheux, D; Hindié, E; Homyrda, L; Schlageter, MH; Thoury, A; Tylski, P; Vercellino, L; Walker, F | 1 |
Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
Angoue, O; Boulahdour, H; Moulin, V; Ojeda-Uribe, M; Porot, C; Thiebault, S; Ungureanu, C | 1 |
Gardin, I; Lelandais, B; Mouchard, L; Ruan, S; Vera, P | 1 |
Fujibayashi, Y; Maruoka, N; Omata, N; Yonekura, Y; Zubal, G | 1 |
Devaskar, SU; Flowers-Ziegler, J; Gambhir, S; Nguyen, K; Sankar, R; Shin, D; Thamotharan, S; Zovein, A | 1 |
Conrad, EU; Farwell, DG; Krohn, KA; Mankoff, DA; Muzi, M; O'Sullivan, F; Peterson, LM; Rajendran, JG; Schwartz, DL; Spence, AM | 1 |
Chan, E; Czernin, J; Fueger, B; Mellinghoff, IK; Sawyers, CL; Thomas, GV; Tran, C; Welsbie, DS | 1 |
Chen, DL; Dehdashti, F | 1 |
Iwamoto, A; Sasaki, T; Tsuboi, H; Watanabe, Y | 1 |
Bacharach, SL; Carson, J; Chan, LW; English, S; Green, MV; Hapdey, S; Krishna, MC; Mitchell, JB; Seidel, J; Sowers, AL | 1 |
Buell, U; Coenen, HH; DiMartino, E; Eble, M; Gagel, B; Hamacher, K; Reinartz, P; Westhofen, M; Zimny, M | 1 |
Kawai, K | 1 |
Adam, MJ; Adomat, H; Dragowska, WH; Fadzli, L; Fazli, L; Gleave, M; Green, D; Kartono, A; Koch, CJ; Oliver, T; Ruth, T; Skov, KA; Sy, J; Woo, J; Yapp, DT | 1 |
Airley, RE; Mobasheri, A | 1 |
Chastagner, P; Fouyssac, F; Karcher, G; Pinel, S; Plenat, F; Poussier, S; Scigliano, S | 1 |
Busk, M; Bussink, J; Horsman, MR; Kristjansen, PE; Overgaard, J; van der Kogel, AJ | 1 |
Flamen, P; Garcia, C | 1 |
Fujibayashi, Y; Maruoka, N; Mitsuya, H; Murata, T; Omata, N; Takamatsu, S; Wada, Y; Yonekura, Y | 1 |
Allen, PS; Brown, WD; Clark, CM; Hochachka, PW; Holden, JE; Nickles, RJ; Stanley, C; Stone, CK; Zhu, GG | 1 |
Fujibayashi, Y; Murata, T; Omata, N; Sadato, N; Waki, A; Yano, R; Yonekura, Y; Yoshida, S; Yoshimoto, M | 1 |
Bentzen, L; Falborg, L; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
Hosono, T; Kawamura, T; Kurabayashi, M; Maeno, T; Maeno, Y; Nagai, R; Sando, Y; Sato, M; Suga, T; Tajima, S | 1 |
Bol, A; de Barsy, T; DeVolder, AG; Goffinet, AM; Laterre, C; Michel, C | 1 |
Ido, T; Ishiwata, K; Kawashima, K; Kono, Y; Matsui, A; Matsuzaka, T; Sakuragawa, N | 1 |
Huang, SC; Krivokapich, J; Phelps, ME; Selin, CE | 1 |
Barrio, JR; Hoffman, EJ; Huang, SC; Krivokapich, J; Nissenson, C; Phelps, ME; Williams, BA | 1 |
17 review(s) available for fluorodeoxyglucose f18 and Hypoxia
Article | Year |
---|---|
Topics: Abdominal Pain; Animals; Biomarkers; Disease Progression; Dyspepsia; Fluorodeoxyglucose F18; Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Mice; Misonidazole; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prevalence; Radiopharmaceuticals; Sleep Wake Disorders | 2021 |
Likely Common Role of Hypoxia in Driving
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2021 |
New methods to image unstable atherosclerotic plaques.
Topics: Annexin A5; Apoptosis; Atherosclerosis; Coronary Artery Disease; Diagnostic Imaging; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Inflammation; Ligands; Magnetic Resonance Imaging; Myocardial Infarction; Neovascularization, Physiologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2018 |
PET/MRI in Breast Cancer.
Topics: Adult; Algorithms; Axilla; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2 | 2019 |
Hypoxia in atherosclerosis and inflammation.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Lipid Metabolism; Macrophages; Magnetic Resonance Angiography; Plaque, Atherosclerotic; Radiography; Signal Transduction | 2013 |
PET imaging of atherosclerosis.
Topics: Atherosclerosis; Calcinosis; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Inflammation; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2015 |
PET-specific parameters and radiotracers in theoretical tumour modelling.
Topics: Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Diffusion; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hydrogen-Ion Concentration; Hypoxia; Misonidazole; Models, Theoretical; Multimodal Imaging; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Tomography, X-Ray Computed | 2015 |
PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer.
Topics: Animals; Chemoradiotherapy; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Processing, Computer-Assisted; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin | 2016 |
Imaging unstable plaque.
Topics: Animals; Arteries; Calcinosis; Cardiovascular Diseases; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Magnetic Resonance Imaging; Mice; Molecular Probes; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2016 |
New molecular probes of vascular inflammation.
Topics: Animals; Apoptosis; Atherosclerosis; Calcinosis; Cardiology; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Mice; Molecular Probes; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Translational Research, Biomedical | 2016 |
Molecular imaging of tumor metabolism and apoptosis.
Topics: Amino Acids; Animals; Apoptosis; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment.
Topics: Animals; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Hypoxia; Immunohistochemistry; Molecular Imaging; Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Advances in positron emission tomographic imaging of lung cancer.
Topics: Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Development trend of PET radiopharmaceuticals as post-FDG tumor imaging agents].
Topics: Amino Acids; Drug Design; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia; Isotope Labeling; Membrane Lipids; Nucleic Acids; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Topics: Anaerobiosis; Animals; Biological Transport; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Glycolysis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography | 2007 |
Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2008 |
2 trial(s) available for fluorodeoxyglucose f18 and Hypoxia
Article | Year |
---|---|
Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron-Emission Tomography; Prospective Studies | 2020 |
Altitude hypoxia increases glucose uptake in human heart.
Topics: Adult; Altitude; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Hypoxia; Lactic Acid; Male; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
75 other study(ies) available for fluorodeoxyglucose f18 and Hypoxia
Article | Year |
---|---|
Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with Spontaneous Tumors and Evaluation for Hypoxia-Directed Therapy.
Topics: Animals; Clostridium; Coordination Complexes; Copper; Copper Radioisotopes; Diacetyl; Dogs; Fluorodeoxyglucose F18; Hypoxia; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2022 |
Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Nocturnal Myoclonus Syndrome; Peptide Fragments; Positron-Emission Tomography; Sleep Apnea, Obstructive; Sleep Deprivation; Sleep Wake Disorders; tau Proteins | 2022 |
The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats.
Topics: Animals; Animals, Newborn; Brain; Brain Injuries; Fluorodeoxyglucose F18; Glucose; Hypoxia; Hypoxia-Ischemia, Brain; Isothiocyanates; Rats; Sulfoxides | 2022 |
Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study.
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Tumor Hypoxia | 2023 |
Intravascular Large B-Cell Lymphoma Presenting with Hypoxemia without any Abnormalities on Standard Imaging Studies.
Topics: Aged; Biopsy; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography | 2019 |
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2022 |
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Hypoxia; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2020 |
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Japan; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoidosis | 2021 |
Hypoxia-induced modulation of glucose transporter expression impacts
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
The Effect of Carbogen Breathing on
Topics: A549 Cells; Animals; Carbon Dioxide; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Hypoxia; Immunohistochemistry; Lung; Lung Neoplasms; Mice; Mice, Nude; Oxygen; Positron-Emission Tomography; Tissue Distribution | 2019 |
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia.
Topics: Adult; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Hypoxia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Microenvironment | 2020 |
2020 vision: New insights on hypoxia imaging to assess cardiac and extra-cardiac active inflammatory sarcoidosis.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Adipose-derived exosomal miR-210/92a cluster inhibits adipose browning via the FGFR-1 signaling pathway in high-altitude hypoxia.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Altitude Sickness; Animals; Exosomes; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Hypoxia; Maillard Reaction; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction | 2020 |
Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.
Topics: Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals | 2021 |
[The 485th case: fever of undetermined origin and hypoxemia].
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2021 |
Acute Hypoxia in a 78-Year-Old Female with Bacteremia and a History of Syphilis.
Topics: Aged; Aneurysm, Ruptured; Aortic Aneurysm, Thoracic; Bacteremia; Bacteroides fragilis; Colonoscopy; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syphilis; Tomography, X-Ray Computed | 2021 |
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study.
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Lung; Positron Emission Tomography Computed Tomography | 2021 |
Vascular Imaging With
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Stroke | 2017 |
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Molecular Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Oxygen; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.
Topics: Alloxan; Animals; Apoptosis; Atherosclerosis; Autoradiography; Body Weight; Cluster Analysis; Diabetes Mellitus, Experimental; Diet, High-Fat; Electrophoresis, Capillary; Femoral Artery; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Macrophages; Mass Spectrometry; Metabolomics; Microscopy, Fluorescence; Nitroimidazoles; Principal Component Analysis; Rabbits | 2017 |
Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function.
Topics: Aorta; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reference Standards | 2017 |
[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.
Topics: Aged; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Retrospective Studies; RNA, Messenger; Stomach Neoplasms; Tumor Burden | 2013 |
PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Mice, Nude; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 2013 |
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Topics: Aged; Coordination Complexes; Cytokines; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones | 2013 |
Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study.
Topics: Algorithms; Animals; Coordination Complexes; Copper Radioisotopes; Dogs; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Glycolysis; Hypoxia; Multimodal Imaging; Neoplasms; Normal Distribution; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Thiosemicarbazones; Tomography, X-Ray Computed | 2013 |
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits.
Topics: Aged; C9orf72 Protein; DNA Repeat Expansion; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Hypoxia; Male; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Proteins | 2014 |
Overexpression of extracellular superoxide dismutase protects against brain injury induced by chronic hypoxia.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biomarkers; Brain Ischemia; Calcium-Binding Proteins; Caspase 3; Cerebellum; Fluorodeoxyglucose F18; Gene Expression; Glial Fibrillary Acidic Protein; Hippocampus; Hypothalamus; Hypoxia; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microtomy; Nerve Tissue Proteins; Positron-Emission Tomography; Superoxide Dismutase; Tissue Culture Techniques; Transgenes | 2014 |
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imidazoles; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2014 |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Neoplasm Grading; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diet; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2015 |
Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.
Topics: Area Under Curve; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results | 2015 |
The increase in tumor oxygenation under carbogen breathing induces a decrease in the uptake of [(18)F]-fluoro-deoxy-glucose.
Topics: Animals; Carbon Dioxide; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Female; Fluorodeoxyglucose F18; Hypoxia; Mice; Mice, Nude; Neoplasms, Experimental; Oximetry; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2015 |
Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.
Topics: Animals; Cell Proliferation; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Glycolysis; Hypoxia; Positron-Emission Tomography; Sarcoma | 2015 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.
Topics: Animals; Binding, Competitive; Biological Transport; Cell Count; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Neoplasms; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Time Factors | 2008 |
In vitro and in vivo evaluations of a hydrophilic 64Cu-bis(thiosemicarbazonato)-glucose conjugate for hypoxia imaging.
Topics: Animals; Carcinosarcoma; Copper Radioisotopes; Fluorodeoxyglucose F18; Glucose; HeLa Cells; Humans; Hypoxia; Male; Oxygen; Positron-Emission Tomography; Rats; Thiosemicarbazones | 2008 |
Measurement of glucose metabolism in rat spinal cord slices with dynamic positron autoradiography.
Topics: Animals; Autoradiography; Brain; Fluorodeoxyglucose F18; Glucose; Hypoxia; Male; Radiopharmaceuticals; Rats; Rats, Wistar; Spinal Cord; Tetrodotoxin | 2009 |
Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Carcinoma, Lewis Lung; Cell Proliferation; Colony-Forming Units Assay; Coordination Complexes; Copper Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Staining and Labeling; Thiosemicarbazones | 2009 |
Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.
Topics: Animals; Carbon Radioisotopes; Disease Models, Animal; Fiducial Markers; Fluorodeoxyglucose F18; Hypoxia; Male; Mice; Neoplasms; Nitroimidazoles; Radionuclide Imaging | 2010 |
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.
Topics: Air; Animals; Autoradiography; Biological Transport; Carbon Dioxide; Cell Proliferation; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; HT29 Cells; Humans; Hypoxia; Mice; Nitroimidazoles; Oxygen; Peritoneal Neoplasms; Respiration | 2010 |
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA, Neoplasm; Female; Fluorodeoxyglucose F18; Genotype; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2010 |
Relationship between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in incidentally detected thyroid cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Vascular Endothelial Growth Factor A | 2010 |
Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Mice, Nude; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Ribosome Inactivating Proteins, Type 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Male; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2012 |
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
Topics: Aorta; Atherosclerosis; Cytokines; Endothelial Cells; Fluorodeoxyglucose F18; Foam Cells; Glucose; Humans; Hydrolysis; Hypoxia; Inflammation; Macrophages; Monocytes; Myocytes, Smooth Muscle; Positron-Emission Tomography | 2011 |
Imaging atherosclerosis with F18-fluorodeoxyglucose positron emission tomography: What are we actually seeing?
Topics: Atherosclerosis; Cardiology; Clinical Trials as Topic; Cytokines; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Macrophages; Positron-Emission Tomography; Research Design | 2011 |
Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Biopsy, Needle; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neck Dissection; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Receptors, Erythropoietin; Registries; Retrospective Studies; Risk Assessment; Survival Analysis; Tongue Neoplasms; Treatment Outcome | 2012 |
Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
Topics: Animals; Fluorodeoxyglucose F18; Glycolysis; Hypoxia; Mice; Neoplasms, Experimental; Radiopharmaceuticals; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Tumor Burden | 2012 |
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Statistics, Nonparametric; Tongue | 2012 |
Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Imaging, Three-Dimensional; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Intrathoracic extramedullary haematopoiesis: the advantages of hybrid imaging.
Topics: Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoiesis, Extramedullary; Humans; Hypoxia; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Thoracic Vertebrae; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Segmentation of biological target volumes on multi-tracer PET images based on information fusion for achieving dose painting in radiotherapy.
Topics: Algorithms; Anthropometry; Bayes Theorem; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Models, Statistical; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Software | 2012 |
Automated kinetic analysis of FDG uptake in living rat brain slices from dynamic positron autoradiography.
Topics: Animals; Autoradiography; Brain; Fluorodeoxyglucose F18; Hypoxia; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 2003 |
Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport.
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Brain Ischemia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose Transporter Type 3; Harderian Gland; Hypoxia; Mice; Mice, Inbred BALB C; Monosaccharide Transport Proteins; Nerve Tissue Proteins; Neurons; Oxygen; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 2004 |
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Topics: Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Hypoxia; Image Processing, Computer-Assisted; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.
Topics: 5' Untranslated Regions; Animals; Brain; Cell Line, Tumor; Densitometry; DNA; DNA Primers; DNA, Complementary; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Kidney Neoplasms; Luciferases; Mice; Neoplasm Transplantation; Polymerase Chain Reaction; Positron-Emission Tomography; Protein Biosynthesis; Protein Kinases; Radiopharmaceuticals; RNA, Messenger; Time Factors; TOR Serine-Threonine Kinases; Transfection | 2006 |
Development of real-time bioradiographic system for functional and metabolic imaging in living brain tissue.
Topics: Acridines; Animals; Autoradiography; Brain; Fluorodeoxyglucose F18; Gamma Cameras; Glucose; Hypoxia; Luminescent Measurements; Male; Organ Culture Techniques; Radiography; Rats; Rats, Wistar; Superoxides | 2006 |
The influence of tumor oxygenation on (18)F-FDG (fluorine-18 deoxyglucose) uptake: a mouse study using positron emission tomography (PET).
Topics: Air; Animals; Female; Fluorodeoxyglucose F18; Hypoxia; Mice; Mice, Inbred C3H; Models, Statistical; Neoplasms; Oxygen; Pilot Projects; Positron-Emission Tomography; Temperature; Time Factors | 2006 |
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Neoplasm Metastasis; Oxygen; Polarography; Positron-Emission Tomography; Reference Standards | 2006 |
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography.
Topics: Androgen Antagonists; Androgens; Animals; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Hypoxia; Male; Mice; Oxygen; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.
Topics: Anemia; Animals; Autoradiography; Electrodes; Erythropoietin; Fluorodeoxyglucose F18; Glioma; Hemoglobins; Humans; Hypoxia; Mice; Mice, Nude; Muscle, Skeletal; Neoplasm Transplantation; Nitroimidazoles; Recombinant Proteins; Transplantation, Heterologous | 2008 |
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
Topics: Aerobiosis; Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypoxia; Immunohistochemistry; Lactic Acid; Mice; Neoplasms; Oxygen; Positron-Emission Tomography | 2008 |
Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treat
Topics: Animals; Brain; Brain Mapping; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Drug Administration Schedule; Fluorodeoxyglucose F18; Hypoxia; In Vitro Techniques; Insulin; Lithium Compounds; Male; Neuroprotective Agents; Positron-Emission Tomography; Rats; Rats, Wistar; Time Factors; Up-Regulation | 2008 |
The brain at high altitude: hypometabolism as a defense against chronic hypoxia?
Topics: Adaptation, Physiological; Adult; Altitude; Brain; Chronic Disease; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Hypoxia; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Tomography, Emission-Computed | 1994 |
Dynamic changes in glucose metabolism of living rat brain slices induced by hypoxia and neurotoxic chemical-loading revealed by positron autoradiography.
Topics: Animals; Autoradiography; Brain; Culture Media; Electrons; Fluorodeoxyglucose F18; Glucose; Hypoxia; In Vitro Techniques; Lactates; Male; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tetrodotoxin | 1999 |
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Topics: Animals; Binding Sites; Carbon Dioxide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hypoxia; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Pulmonary intravascular lymphoma complicated with Pneumocystis carinii pneumonia: a case report.
Topics: Aged; Dementia; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Pneumocystis; Radionuclide Imaging; Vascular Neoplasms | 2001 |
Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study.
Topics: Adult; Autoradiography; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Male; Periaqueductal Gray; Syndrome; Tissue Distribution; Tomography, Emission-Computed | 1990 |
Enhanced glucose metabolism and impaired placental function in hypoxic pregnant rats.
Topics: Animals; Antipyrine; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hypoxia; Placenta; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred Strains | 1988 |
Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart.
Topics: Animals; Blood Flow Velocity; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Glucosephosphates; Hypoxia; Insulin; Kinetics; Models, Theoretical; Myocardium; Rabbits | 1987 |
Measurement of glucose and 2-deoxy-2-[18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments.
Topics: Animals; Biological Transport; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Heart Septum; Hypoxia; Kinetics; Lactates; Lactic Acid; Myocardium; Phosphorylation; Rabbits | 1987 |